Home > Neurology > EAN 2021 > COVID-19 > Neurological symptoms and complications of COVID-19 affect outcomes

Neurological symptoms and complications of COVID-19 affect outcomes

Presented By
Dr Nina Kleineberg, University Hospital Cologne, Germany
Conference
EAN 2021
New findings from a large German registry study shed more light on the neurological implications of COVID-19 and the factors affecting outcomes. Patients with pre-existing neuro-immunological diseases and prior cerebrovascular events did not seem to have an elevated risk of unfavourable outcomes or complicated disease course. Dr Nina Kleineberg (University Hospital Cologne, Germany) presented findings from the Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS), based on data from 6,537 patients from 127 centres across Europe with a diagnosis of SARS-CoV-2 infection between January 2020 and February 2021 [1]. In total, 92.1% of patients in this cohort were hospitalised. More than half (54.4%) had ≥1 neurological symptom, 3.3% had a new neurological complication, and 18.1% had ≥1 pre-existing neurological comorbidities. The neurological manifestations (see Table 1) and complications (see Table 2) in this study were mostly in agreement w...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on